Every year, millions of patients pay their health insurance premiums, trusting their insurer will be there to support them if something happens. What they don’t know is that the same company they’re depending on is pocketing their premiums and taking a cut of their prescription payments. For the tens of millions of Americans enrolled in UnitedHealthcare plans, their prescriptions are being routed through UnitedHealth’s own pharmacy benefit manager (PBM), OptumRx, generating billions in financial windfall.
Unfortunately, UnitedHealth is not an outlier but the blueprint for major health insurers. Across the country, the same vertical integration model, where an insurer operates through its own PBM—which also owns a pharmacy—has quietly become the routine structure of American healthcare and the reason patients continue to be charged outrageous prices at the pharmacy counter. This model lets one company set the price, choose the drug, and pocket the difference, with no market check on any of it. As this consolidation has grown, competition has shrunk, driving up costs, reducing competition, and eroding transparency.